TABLE 1.
Sample type and no. | No. of NGS reads: |
No. of unique reads 17–200 nt mapping to VZV genome | No. of reads 17–24 nt mapping to VZV genome | |
---|---|---|---|---|
17–200 nt | 17–24 nt aligned to human genome | |||
Neurons | ||||
Uninfected | ||||
1 | 15,409,516 | 7,234,809 | 0 | 0 |
2 | 18,535,803 | 15,941,006 | 2 | 0 |
3 | 15,688,047 | 7,917,409 | 3 | 0 |
Infected | ||||
1 | 14,167,260 | 5,323,812 | 6,693 | 482 |
2 | 16,747,763 | 13,481,851 | 12,282 | 1,645 |
3 | 15,012,737 | 8,171,776 | 23,339 | 858 |
Latently infected | ||||
1 | 13,620,130 | 4,129,576 | 28 | 10 |
2 | 15,885,742 | 11,004,344 | 94 | 41 |
3 | 13,987,171 | 6,663,047 | 65 | 29 |
Infected fibroblasts | ||||
1 | 14,092,008 | 4,830,665 | 11,458 | 3,160 |
2 | 11,473,036 | 8,660,687 | 8,019 | 2,015 |
3 | 11,633,714 | 6,879,540 | 9,693 | 2,437 |